Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
Fierce Biotech
Thu, 10/21/21 - 10:35 am
Menarini
Radius Health
breast cancer
clinical trials
Elacestrant
Keytruda maker Merck rolls web series to illuminate triple-negative breast cancer and Black women
Fierce Pharma
Wed, 10/20/21 - 06:49 pm
Merck
breast cancer
pharma marketing
triple negative breast cancer
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
Motley Fool
Thu, 10/14/21 - 11:00 am
AstraZeneca
breast cancer
clinical trials
Enhertu
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Wed, 10/13/21 - 11:07 am
Eli Lilly
Verzenio
FDA
early breast cancer
breast cancer
Enhertu nabs speedy FDA review for earlier use in breast cancer
Pharmaforum
Mon, 10/4/21 - 10:57 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
FDA
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
Fierce Biotech
Mon, 09/20/21 - 12:00 pm
ESMO
Syros Pharmaceuticals
breast cancer
Pfizer
Ibrance
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Drugs.com
Sun, 09/19/21 - 11:58 pm
ESMO
Novartis
clinical trials
Kisqali
breast cancer
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
ESMO
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Roche
ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs
Pharmaforum
Fri, 09/17/21 - 11:36 am
Roche
Giredestrant
Serds
breast cancer
ESMO
AstraZeneca
Faslodex
ESMO 2021 – the jury remains out on CDK7 inhibition
EP Vantage
Fri, 09/17/21 - 11:02 am
ESMO
Syros Pharmaceuticals
Carrick Therapeutics
breast cancer
Spine devices, recalls and endovascular stents on FDA's fall meeting lineup
Medtech Dive
Thu, 09/9/21 - 11:03 am
FDA
devices
Medtech
Endologix
Integra
spinal device
breast cancer
device recalls
endovascular stents
MacroGenics flips over an OS dud for cancer drug Margenza in surprising turnaround from earlier data
Endpoints
Tue, 09/7/21 - 10:48 pm
Macrogenics
breast cancer
Margenza
Roche pulls Tecentriq breast cancer nod after post-approval trial flop
Fierce Pharma
Sat, 08/28/21 - 09:04 pm
Roche
Tecentriq
breast cancer
triple negative breast cancer
postmarketing studies
FDA issues warning on robot-assisted breast cancer surgery
Pharmaforum
Sun, 08/22/21 - 09:48 pm
FDA
robotic surgery
masectomy
breast cancer
Two More Cancer Drug Candidates Hit the Fast Track
BioSpace
Mon, 08/16/21 - 12:16 pm
ovarian cancer
breast cancer
fast track status
IN10018
InxMed
Carrick Therapeutics
samuraciclib
SeaGen builds cancer drug pipeline with China biotech deal
BioPharma Dive
Mon, 08/9/21 - 11:47 pm
Seagen
China
breast cancer
bladder cancer
stomach cancer
RemeGen
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Merck rebounds to win a milestone immunotherapy approval in early breast cancer
BioPharma Dive
Tue, 07/27/21 - 04:39 pm
FDA
Merck
Keytruda
breast cancer
The search for a better Faslodex continues
EP Vantage
Mon, 07/26/21 - 10:12 pm
breast cancer
drug development
Serds
Pfizer
Arvinas
Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table
Fierce Biotech
Thu, 07/22/21 - 11:15 am
Pfizer
Arvinas
breast cancer
protein degradation
biobucks
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »